^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Cutaneous Melanoma
    Drug:Zyclara (imiquimod) (TLR8 agonist, TLR7 agonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    01/26/2022
    Excerpt:
    melanoma: Cutaneous...INITIAL TREATMENT...Unresectable disease...Topical imiquimod...